DK0738715T3 - Arylalkyl-pyridazinoner. - Google Patents

Arylalkyl-pyridazinoner.

Info

Publication number
DK0738715T3
DK0738715T3 DK96105702T DK96105702T DK0738715T3 DK 0738715 T3 DK0738715 T3 DK 0738715T3 DK 96105702 T DK96105702 T DK 96105702T DK 96105702 T DK96105702 T DK 96105702T DK 0738715 T3 DK0738715 T3 DK 0738715T3
Authority
DK
Denmark
Prior art keywords
cooa
substd
halo
opt
alkyl
Prior art date
Application number
DK96105702T
Other languages
Danish (da)
English (en)
Inventor
Rochus Dr Jonas
Michael Dr Wolf
Norbert Dr Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Application granted granted Critical
Publication of DK0738715T3 publication Critical patent/DK0738715T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK96105702T 1995-04-20 1996-04-11 Arylalkyl-pyridazinoner. DK0738715T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19514568A DE19514568A1 (de) 1995-04-20 1995-04-20 Arylalkyl-pyridazinone

Publications (1)

Publication Number Publication Date
DK0738715T3 true DK0738715T3 (da) 2003-05-26

Family

ID=7759974

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96105702T DK0738715T3 (da) 1995-04-20 1996-04-11 Arylalkyl-pyridazinoner.

Country Status (21)

Country Link
US (2) US6399611B1 (cs)
EP (1) EP0738715B1 (cs)
JP (1) JP4005157B2 (cs)
KR (1) KR100428879B1 (cs)
CN (1) CN1159299C (cs)
AT (1) ATE231842T1 (cs)
AU (1) AU705025B2 (cs)
CA (1) CA2174472C (cs)
CZ (1) CZ291868B6 (cs)
DE (2) DE19514568A1 (cs)
DK (1) DK0738715T3 (cs)
ES (1) ES2191070T3 (cs)
HU (1) HU226198B1 (cs)
NO (1) NO307931B1 (cs)
PT (1) PT738715E (cs)
RU (1) RU2159236C2 (cs)
SI (1) SI0738715T1 (cs)
SK (1) SK284167B6 (cs)
TW (1) TW475927B (cs)
UA (1) UA43853C2 (cs)
ZA (1) ZA963154B (cs)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533975A1 (de) * 1995-09-14 1997-03-20 Merck Patent Gmbh Arylalkyl-diazinone
JP4017214B2 (ja) 1996-06-11 2007-12-05 興和創薬株式会社 ５−フェニル−３−ピリダジノン誘導体
CA2264685C (en) * 1996-08-27 2002-10-15 Kyoji Noda 2-phenylmorpholin-5-one derivatives and pharmaceutical composition comprising the same
CN1173950C (zh) * 1998-10-06 2004-11-03 大日本制药株式会社 2,3-二取代的吡啶衍生物、其制备方法、含有其的药物组合物和用于制备中的中间体
DE19850701A1 (de) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
NZ517166A (en) 1999-08-21 2004-01-30 Altana Pharma Ag Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonists
RU2279428C2 (ru) * 2000-09-18 2006-07-10 Эйсай Ко., Лтд. Производные пиридазинона и триазинона и их применение в качестве фармацевтических препаратов
DE10064997A1 (de) * 2000-12-23 2002-06-27 Merck Patent Gmbh Benzoylpyridazine
CN1235589C (zh) * 2001-02-12 2006-01-11 默克专利股份公司 4型磷酸二酯酶抑制剂在制备治疗心肌疾病药物中的应用
US6872382B1 (en) 2001-05-21 2005-03-29 Alcon, Inc. Use of selective PDE IV inhibitors to treat dry eye disorders
KR20040007583A (ko) * 2001-05-23 2004-01-24 다나베 세이야꾸 가부시키가이샤 연골 질환의 재생치료용 조성물
WO2002094321A1 (en) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions for promoting healing of bone fracture
DE10150517A1 (de) * 2001-10-12 2003-04-17 Merck Patent Gmbh Verwendung von Phosphodiesterase IV-Inhibitoren
US20040259863A1 (en) * 2001-10-31 2004-12-23 Hans-Michael Eggenweiler Type 4 phosphodiesterase inhibitors and uses thereof
ES2195785B1 (es) * 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
US7074959B2 (en) * 2002-08-01 2006-07-11 New Mexico Highlands University Methods and systems for remediating hydrazine-contaminated equipment and/or surfaces
ES2211344B1 (es) * 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
EP1624893A2 (en) 2003-04-01 2006-02-15 Applied Research Systems ARS Holding N.V. Inhibitors of phosphodiesterases in infertility
WO2005075437A1 (en) * 2004-02-04 2005-08-18 Altana Pharma Ag Pyridazinone derivatives and their use as pde4 inhibitors
ES2304692T3 (es) * 2004-02-04 2008-10-16 Nycomed Gmbh Derivados de 2-(piperidin-4-il)-4,5-dihidro-2h-piridazin-3-ona como inhibidores de pde4.
ES2251867B1 (es) * 2004-06-21 2007-06-16 Laboratorios Almirall S.A. Nuevos derivados de piridazin-3(2h)-ona.
MX2009006312A (es) * 2006-12-14 2009-08-07 Astellas Pharma Inc Compuestos de acido policiclico utiles como antagonistas crth2 y agentes antialergicos.
US8466198B2 (en) * 2008-09-02 2013-06-18 Bruce Kneller Compositions comprising creatine salts and methods of use thereof
EP2298090B1 (en) * 2009-08-26 2016-01-13 Jeffrey M. Golini Pharmaceutical or nutraceutical composition
KR102520814B1 (ko) 2016-03-16 2023-04-11 에이치 리 모피트 캔서 센터 앤드 리서어치 인스티튜트 아이엔씨 작동자 t 세포 기능 개선을 위한 세레브론에 대한 소분자
WO2020014489A2 (en) 2018-07-11 2020-01-16 H. Lee Moffitt Cancer Center And Research Institute, Inc. Dimeric immuno-modulatory compounds against cereblon-based mechanisms

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1604863A (cs) * 1967-11-22 1972-04-17
US3975388A (en) * 1971-02-22 1976-08-17 Bdh Pharmaceuticals Limited Pyridazinones
GB1488330A (en) * 1973-12-19 1977-10-12 Smith Kline French Lab Dihydropyridazinones
DE2845456A1 (de) 1978-10-19 1980-08-14 Merck Patent Gmbh 6-arylpyridazin-3-one und verfahren zu ihrer herstellung
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
SU1313346A3 (ru) * 1981-09-17 1987-05-23 Варнер-Ламберт,Компани (Фирма) Способ получени замещенных 6-арил-3(2 @ )-пиридазинонов
US4734415A (en) * 1982-08-13 1988-03-29 Warner-Lambert Company Substituted 4,5-dihydro-6-(substituted)-phenyl-3(2H)-pyridazinones and 6-(substituted) phenyl-3(2H)-pyridazinones
GR82072B (cs) * 1983-05-11 1984-12-13 Byk Gulden Lomberg Chem Fab
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
US4816454A (en) * 1984-09-21 1989-03-28 Cassella Aktiengesellschaft 4,5-dihydro-3(2H)-pyridazinones and their pharmacological use
JPS61158969A (ja) * 1984-12-24 1986-07-18 ワーナー‐ランバート・コンパニー ４，５‐ジヒドロ‐４，４‐ジアルキル‐６‐（置換）フエニル‐３（２ｈ）‐ピリダジノン類
DE3704879A1 (de) * 1987-02-17 1988-08-25 Merck Patent Gmbh Pyridazinonderivate
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
US5175161A (en) * 1989-04-06 1992-12-29 Sankyo Company, Limited Occular hypotensive agents
KR910004574A (ko) * 1989-08-10 1991-03-28 글락소 인크 강심 작용 및 베타 차단 작용을 갖는 피리다지논류
DE4237656A1 (de) * 1992-06-13 1993-12-16 Merck Patent Gmbh Benzimidazolderivate
JP2806192B2 (ja) * 1992-11-02 1998-09-30 日本曹達株式会社 血小板凝集抑制剤
DE19502699A1 (de) 1995-01-28 1996-08-01 Merck Patent Gmbh Arylalkyl-thiadiazinone

Also Published As

Publication number Publication date
US6399611B1 (en) 2002-06-04
US6531473B2 (en) 2003-03-11
KR960037662A (ko) 1996-11-19
TW475927B (en) 2002-02-11
AU5071196A (en) 1996-10-31
HU226198B1 (en) 2008-06-30
SK284167B6 (sk) 2004-10-05
SI0738715T1 (en) 2003-10-31
SK48796A3 (en) 1997-02-05
CN1159299C (zh) 2004-07-28
NO307931B1 (no) 2000-06-19
CZ291868B6 (cs) 2003-06-18
JP4005157B2 (ja) 2007-11-07
HUP9601034A2 (en) 1996-12-30
ZA963154B (en) 1996-12-06
JPH08291145A (ja) 1996-11-05
EP0738715A2 (de) 1996-10-23
CA2174472C (en) 2008-10-21
UA43853C2 (uk) 2002-01-15
AU705025B2 (en) 1999-05-13
EP0738715A3 (de) 1998-06-17
PT738715E (pt) 2003-06-30
CA2174472A1 (en) 1996-10-21
NO961578L (no) 1996-10-21
KR100428879B1 (ko) 2004-07-15
DE59610081D1 (de) 2003-03-06
CZ113296A3 (en) 1996-11-13
RU2159236C2 (ru) 2000-11-20
CN1142493A (zh) 1997-02-12
EP0738715B1 (de) 2003-01-29
ATE231842T1 (de) 2003-02-15
HU9601034D0 (en) 1996-06-28
ES2191070T3 (es) 2003-09-01
NO961578D0 (no) 1996-04-19
HUP9601034A3 (en) 1999-03-01
US20020111356A1 (en) 2002-08-15
DE19514568A1 (de) 1996-10-24

Similar Documents

Publication Publication Date Title
DK0738715T3 (da) Arylalkyl-pyridazinoner.
NO954366D0 (no) Adhesjonsreseptorantagonister
CZ215495A3 (en) Ortho-substituted methyl amides of 2-methoxyiminophenylacetic acid
HU9503933D0 (en) Aryl-alkyl-thiadiazinones
NO953253D0 (no) Adhesjonsreseptorantagonister
PT758644E (pt) Derivados de sulfonil- ou sulfinil-benzoil-guanidina
SI0737678T1 (en) 4-Indolylpiperazinyl derivatives
NO970513D0 (no) Urokinase-reseptorligander
HU9602331D0 (en) Alkenyl-benzoyl-guanidine derivatives
NO963374D0 (no) Substituerte 4H-pyraner
ATE176903T1 (de) Cyclohexadienderivate
DK0758647T3 (da) Acylsubstituerede aminopyraner med en modulerende virkning på kaliumkanaler